These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 31792895

  • 1. Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.
    Naphade S, Tshilenge KT, Ellerby LM.
    Neurotherapeutics; 2019 Oct; 16(4):979-998. PubMed ID: 31792895
    [Abstract] [Full Text] [Related]

  • 2. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.
    HD iPSC Consortium.
    Cell Stem Cell; 2012 Aug 03; 11(2):264-78. PubMed ID: 22748968
    [Abstract] [Full Text] [Related]

  • 3. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.
    Sánchez I, Mahlke C, Yuan J.
    Nature; 2003 Jan 23; 421(6921):373-9. PubMed ID: 12540902
    [Abstract] [Full Text] [Related]

  • 4. Polyalanine and polyserine frameshift products in Huntington's disease.
    Davies JE, Rubinsztein DC.
    J Med Genet; 2006 Nov 23; 43(11):893-6. PubMed ID: 16801344
    [Abstract] [Full Text] [Related]

  • 5. Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.
    Tydlacka S, Wang CE, Wang X, Li S, Li XJ.
    J Neurosci; 2008 Dec 03; 28(49):13285-95. PubMed ID: 19052220
    [Abstract] [Full Text] [Related]

  • 6. DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis.
    Thiruvalluvan A, de Mattos EP, Brunsting JF, Bakels R, Serlidaki D, Barazzuol L, Conforti P, Fatima A, Koyuncu S, Cattaneo E, Vilchez D, Bergink S, Boddeke EHWG, Copray S, Kampinga HH.
    Mol Cell; 2020 Apr 16; 78(2):346-358.e9. PubMed ID: 32268123
    [Abstract] [Full Text] [Related]

  • 7. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.
    Ross CA.
    Neuron; 2002 Aug 29; 35(5):819-22. PubMed ID: 12372277
    [Abstract] [Full Text] [Related]

  • 8. The pathogenic agent in Drosophila models of 'polyglutamine' diseases.
    McLeod CJ, O'Keefe LV, Richards RI.
    Hum Mol Genet; 2005 Apr 15; 14(8):1041-8. PubMed ID: 15757976
    [Abstract] [Full Text] [Related]

  • 9. [Polyglutamine diseases: a pathologic view].
    Yamada M.
    Rinsho Shinkeigaku; 2003 Nov 15; 43(11):903-5. PubMed ID: 15152499
    [Abstract] [Full Text] [Related]

  • 10. RNA Editing by ADAR Adenosine Deaminases in the Cell Models of CAG Repeat Expansion Diseases: Significant Effect of Differentiation from Stem Cells into Brain Organoids in the Absence of Substantial Influence of CAG Repeats on the Level of Editing.
    Kudriavskii VV, Goncharov AO, Eremeev AV, Ruchko ES, Veselovsky VA, Klimina KM, Bogomazova AN, Lagarkova MA, Moshkovskii SA, Kliuchnikova AA.
    Biochemistry (Mosc); 2024 Aug 15; 89(8):1474-1489. PubMed ID: 39245456
    [Abstract] [Full Text] [Related]

  • 11. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
    Kennedy L, Shelbourne PF.
    Hum Mol Genet; 2000 Oct 12; 9(17):2539-44. PubMed ID: 11030759
    [Abstract] [Full Text] [Related]

  • 12. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH, Charles V, Williams M, Miller G, Whetsell WO, Tagle DA.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1035-45. PubMed ID: 10434303
    [Abstract] [Full Text] [Related]

  • 13. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J, Bradley J, Brown R, Maxwell M, Schapira A, Orntoft TF, Kato K, Rubinsztein DC.
    Hum Mol Genet; 2001 Aug 15; 10(17):1829-45. PubMed ID: 11532992
    [Abstract] [Full Text] [Related]

  • 14. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.
    An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM.
    Cell Stem Cell; 2012 Aug 03; 11(2):253-63. PubMed ID: 22748967
    [Abstract] [Full Text] [Related]

  • 15. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
    Hannan AJ.
    Acta Biochim Pol; 2004 Aug 03; 51(2):415-30. PubMed ID: 15218539
    [Abstract] [Full Text] [Related]

  • 16. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
    Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, Ming GL, Song H.
    Mol Brain; 2012 May 21; 5():17. PubMed ID: 22613578
    [Abstract] [Full Text] [Related]

  • 17. [The Role of Mutant RNA in the Pathogenesis of Huntington's Disease and Other Polyglutamine Diseases].
    Bogomazova AN, Eremeev AV, Pozmogova GE, Lagarkova MA.
    Mol Biol (Mosk); 2019 May 21; 53(6):954-967. PubMed ID: 31876275
    [Abstract] [Full Text] [Related]

  • 18. Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.
    Reis SD, Pinho BR, Oliveira JMA.
    Mol Neurobiol; 2017 Oct 21; 54(8):5829-5854. PubMed ID: 27660272
    [Abstract] [Full Text] [Related]

  • 19. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
    Davies SW, Beardsall K, Turmaine M, DiFiglia M, Aronin N, Bates GP.
    Lancet; 1998 Jan 10; 351(9096):131-3. PubMed ID: 9439509
    [Abstract] [Full Text] [Related]

  • 20. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
    Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y, Lee DS, Seo KS, Choi NJ, Park BC, Kang SH, Ryu J, Oh SH, Shin DA, Lee DR, Do JT, Park IH, Daley GQ, Song J.
    Biochem J; 2012 Sep 15; 446(3):359-71. PubMed ID: 22694310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.